TNFSF10 and cancer: As an expressible peptide, TRAIL has great potential because it is non-toxic to most normal tissues, unlike TNF-α (Ashkenazi et al, 1999; Cretney et al, 2006), and because bacterially produced TRAIL has been shown to be cytotoxic to cancer cells (Kim et al, 2004).